Home/Filings/4/0001209191-17-062225
4//SEC Filing

Del Fosse Franc 4

Accession 0001209191-17-062225

CIK 0001516479other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 9:04 PM ET

Size

5.4 KB

Accession

0001209191-17-062225

Insider Transaction Report

Form 4
Period: 2017-11-17
Del Fosse Franc
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2017-11-17+25,00025,000 total
    Exercise: $5.37Exp: 2027-11-16Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option shall vest in 36 equal monthly installments until fully vested and exercisable on November 17, 2020.

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeother

Related Parties

1
  • filerCIK 0001617058

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 9:04 PM ET
Size
5.4 KB